Clinical adverse events to voclosporin: a real-world drug safety study based on FDA Adverse Event Reporting System. (PubMed, Clin Exp Rheumatol) - Jul 30, 2025 - "The present research provides a significant assessment of the postmarketing safety profile of voclosporin. However, additional studies are needed to corroborate and solidify these observations. Clinicians are advised to remain highly vigilant about the potential AEs associated with voclosporin and to carefully consider the appropriate dosing regimens when utilising this medication in clinical practice."
Adverse events • Journal • Real-world evidence • Cardiovascular • Dermatology • Gastroenterology • Gastrointestinal Disorder • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Hui Huang; Jiaqi Zhang; Liheng Liu; Pingping Li; Ruxuan Chen; Yan Tang; Yanjun Wan; Yujie Shi
|